Hepatitis: all 3,372 studies
Page 20 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Hepatitis B Vaccination in HIV-infected AdultsCompletedNCT02713620Phase 4
- Testing and Treating Hepatitis C in Community PharmaciesCompletedNCT02706223Not applicable
- Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV HepatitisStatus unknownNCT02705742Phase 1/2
- Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1CompletedNCT02705534Phase 3
- Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.CompletedNCT02697474Phase 3
- A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B VaccineCompletedNCT02693652Phase 1/2
- Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCVCompletedNCT02690103Phase 2
- Chronic Hepatitis B and C Recall Northern HollandStatus unknownNCT02687061
- Study of Hepatitis C Treatment During PregnancyCompletedNCT02683005Phase 1
- A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)CompletedNCT02662712Phase 1
- HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-InfectionCompletedNCT02660905Phase 3
- Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver DiseaseWithdrawnNCT02658786
- EDP-494-001: A Study of EDP-494 in Healthy Subjects and Hepatitis C PatientsCompletedNCT02652377Phase 1
- Impact of Hepatitis C Virus Therapy on Central Nervous System OutcomesCompletedNCT02650024
- Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With and Without Ribavirin in Protease-Inhibitors ("PI") FailuresStatus unknownNCT02646111Phase 3
- Epidemiological Study of Hepatitis E Virus in Maintenance Hemodialysis PatientsCompletedNCT02645955
- Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.CompletedNCT02641158Not applicable
- Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis CStatus unknownNCT02639585Phase 4
- Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/PCompletedNCT02634008Phase 3
- Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1CompletedNCT02629172
- Interferon/Ribavirin-Free Sofosbuvir Based Treatment (AURIC)CompletedNCT02628717
- Monitoring Liver Disease Progression in Hepatitis C/HIV Co-infected Patients With No-to-moderate Fibrosis, in Phnom Penh, CambodiaTerminatedNCT02628691
- Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)CompletedNCT02624063Phase 4
- A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHBStatus unknownNCT02615639Phase 1/2
- Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of AgeCompletedNCT02610348Not applicable
- Hepatitis B in Cystic Fibrosis and Latent Tuberculosis RespectivelyWithdrawnNCT02605538Not applicable
- New Strategy Study of Functional Cure of Chronic Hepatitis BStatus unknownNCT02605252Not applicable
- A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV)CompletedNCT02604823Phase 4
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7020322 Following Oral Administration in Healthy Participants and Chronic Hepatitis B PatientsTerminatedNCT02604355Phase 1
- A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy AdultsCompletedNCT02603055Phase 1
- Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A VaccinesCompletedNCT02601040Phase 4
- Use of TDF in Patients With Inactive Chronic Hepatitis B InfectionCompletedNCT02600117Phase 3
- A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis BCompletedNCT02598063Phase 4
- An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV InfectionCompletedNCT02597270
- Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 InfectionCompletedNCT02597166Phase 3
- Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) CirrhoticsCompletedNCT02596880Phase 3
- Bartonella in Liver Transplant PatientsCompletedNCT02595710
- Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC TherapyCompletedNCT02594293Phase 4
- A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus InfectionCompletedNCT02593162Phase 2
- Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in IndiaCompletedNCT02592057
- Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir TherapyStatus unknownNCT02589652
- Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® TabletCompletedNCT02589457Phase 1
- Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B PatientsStatus unknownNCT02588937Phase 4
- Viral Load Changes in Lymphoma Patients With HCV Infection After ChemotherapyStatus unknownNCT02588560
- A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)CompletedNCT02584543Phase 4
- Project BEST: Buprenorphine Entry Into Substance Abuse TreatmentCompletedNCT02583243
- Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B PatientsStatus unknownNCT02581033Not applicable
- The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese SubjectsCompletedNCT02581020
- Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)CompletedNCT02578693
- Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected PatientsCompletedNCT02576314Phase 3
- Identification of Viral Variants Involved in the Transmission of Hepatitis C and Characterization of Antigenic and Functional Properties of Their Envelope GlycoproteinsCompletedNCT02574884Not applicable
- Antiviral Pharmacology and Adherence in Drug UsersCompletedNCT02573376Not applicable
- A Study of PEGASYS (Peginterferon Alfa-2a [40KD]) in Patients With Hepatitis B e Antigen (HBeAg)-Negative Chronic Hepatitis B Virus (HBV)CompletedNCT02570191Phase 4
- A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B PatientsCompletedNCT02569372Phase 1
- C Tracker, Hepatitis C, Care & Collaboration - Patient Reported Outcomes Survey StudyTerminatedNCT02568540
- Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-FranceCompletedNCT02566148
- A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/CobicistatCompletedNCT02565888Phase 1
- A Drug-drug Interaction Study Between Daclatasvir and MetforminCompletedNCT02565862Phase 1
- REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B InfectionCompletedNCT02565719Phase 2
- Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement TherapyWithdrawnNCT02563665
- Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus InfectionCompletedNCT02562742
- Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.TerminatedNCT02558114Phase 4
- Liver Test Study of Using JKB-122 in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current TherapiesCompletedNCT02556372Phase 2
- A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)WithdrawnNCT02556086Phase 2
- DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO)CompletedNCT02555943Phase 2/3
- The Prime Study - Comparing Hepatitis C Care and Treatment in a Primary Health Care Service With a Tertiary HospitalCompletedNCT02555475Not applicable
- A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 3WithdrawnNCT02551861Phase 2
- Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric StudyCompletedNCT02548325
- Quantification of Side Effects During Hepatitis C TherapyCompletedNCT02545400
- Hepatitis C Virus in Neutrophil Granulocyte Progenitor CellsWithdrawnNCT02545387
- Neutrophil Function During Therapy With Protease Inhibitors in Chronic Hepatitis CCompletedNCT02545335
- Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus InfectionCompletedNCT02537379
- Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis BCompletedNCT02533544
- Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis BStatus unknownNCT02532413Phase 4
- Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization PeriodCompletedNCT02531269
- Macrophage Activation Markers During Sofosbuvir-based Treatment Regimes of Chronic Hepatitis CCompletedNCT02528461
- Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis CCompletedNCT02526641
- Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With BaracludeStatus unknownNCT02523547Phase 4
- Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus InfectionCompletedNCT02511743
- Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in AndalusiaStatus unknownNCT02511496
- Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the PregnancyStatus unknownNCT02510963Not applicable
- A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection TrialsTerminatedNCT02510300
- Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus RibavirinCompletedNCT02508090
- Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA RegimensCompletedNCT02505243
- A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic HepatitisCompletedNCT02499562Phase 2
- A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus InfectionCompletedNCT02498015Phase 4
- A Phase 3 Evaluation of Daclatasvir and Asunaprevir in Treatment-naive Subjects With Chronic Hepatitis C Genotype 1b InfectionCompletedNCT02496078Phase 3
- Outcome of New Direct Acting Agents For Hepatitis C A Community Based ExperienceStatus unknownNCT02485262
- Rifaximin Use in Severe Alcoholic HepatitisStatus unknownNCT02485106Phase 3
- Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1WithdrawnNCT02485080Phase 4
- Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis BStatus unknownNCT02482272Phase 4
- Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected PatientsCompletedNCT02482077Phase 4
- A Community-based, Behavioral Intervention to Improve Screening for Hepatitis C Among High-risk Young Adults in WisconsinCompletedNCT02474043Not applicable
- Way to Cure HCV AdherenceCompletedNCT02472925Not applicable
- Neurocognitive Performance and Emotional State in HCV Patients With IFN-free Antiviral TherapyStatus unknownNCT02469012Not applicable
- Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis BStatus unknownNCT02463019Phase 4
- Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic HepatitisCompletedNCT02458079Not applicable
- Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B VaccineCompletedNCT02445703Phase 4
- A Trial Investigating the Influence of BCG and Hepatitis B Immunisation at Birth on Neonatal Immune Responses: The Early Life Vaccines and Immunity StudyCompletedNCT02444611Not applicable
- Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong KongCompletedNCT02443233